Latest News
Dublin-based renewable energy group Gaelectric has agreed in excess of EUR90m in additional financing for its business.
Gaelectric, with its team of 50 employees, is active in the development and operation of wind and energy storage projects in Ireland, the US and the UK.
BlueBay Ireland Corporate Credit, a vehicle established by BlueBay Asset Management with substantial investment from the National Pensions Reserve Fund of Ireland to provide loans to larger SMEs and mid-sized corporates, is providing EUR30m in business development and expansion funding, which will be available to support the growth of all aspects of Gaelectric's business.
Clairvest Group has made a USD28.5m investment in Winters Bros Waste Systems of CT, its fourth investment in the waste management industry.
Winters Bros of CT is a privately-owned, regional solid waste collection, recycling and disposal company based in Danbury, Connecticut. The company provides residential, commercial and industrial waste and recycling collection services in western and south-western Connecticut as well as in Westchester County and Putnam County in New York.
Winters Bros. of CT also operates several transfer stations and a single stream recycling facility.
Clairvest's portion of the investment is USD7.6m.
Clairvest is partnering with Joe
Mergers and acquisitions (M&A) targeting companies in Western Europe in November rose in terms of aggregate deal value with an eight per cent increase recorded against a 23 per cent decline by volume.
There were 1,537 deals worth a combined EUR49,761m in November, compared to 2,007 transactions valued at EUR46,277m in October, according to information collected by the M&A database Zephyr.
The picture is less positive in a year-on-year comparison as volume was down on 12 months ago (November 2012: 1,911). Value also failed to reach the EUR60,386m recorded in November 2012.
Private equity and venture capital investments
Many UK mid-market companies are failing to recognise the benefits of non-bank lending as a source of long-term funding, according to a panel of industry participants at an event hosted by Standard & Poor's Ratings.
"Bank deleveraging and tightening regulation are creating a scarcity of finance for many companies in Europe," says Standard & Poor's vice president of market development EMEA Roberto Rivero. "But this scarcity is particularly acute for the so-called "squeezed middle" – UK companies with revenues of between GBP85m and GBP1.3bn – which we estimate will need up to GBP450bn in debt funding over the next five
21 Partners has sold Almaviva Santé, a network of private clinics in the Marseille region, to a consortium of private equity investors including GIMV and UI Gestion.
Founded in 2007 by 21 Partners and CEO entrepreneur Bruno Marie, Almaviva Santé is composed of seven clinics, all top-rated in the south of France.
The company has leading practices in the fields of orthopaedic and ophthalmic surgery.
21 Partners has supported Almaviva Santé in the structuring of its platform to improve efficiency through the development of a group quality standard policy.
With a staff of over 600 practitioners and
International banks and other investors considering public private partnership (PPP) investments in Scotland are already seeking legal opinions as to what would happen if Scotland broke away from the UK, says City law firm RPC.
RPC says that a number of its international financial institution clients are concerned about investing in projects in Scotland via a PPP because the projects could potentially lose the implied guarantee of the UK Government if Scotland votes to withdraw from the UK.
Many PPP projects in Scotland are backed by local authorities or other public sector bodies that could fall under the responsibility
KKR is to acquire a minority stake in Gland Pharma, an Indian pure-play generic injectable pharmaceutical products company, for approximately USD200m.
This includes KKR acquiring the entire stake held by Evolvence India Life Sciences Fund (EILSF), an existing private equity investor in Gland Pharma.
Established in 1978 and based in Hyderabad, Gland Pharma develops and manufactures generic injectables primarily for the US market and also for India and other semi-regulated markets. In 2003, Gland Pharma was the first company in India to get US Food and Drug Administration (FDA) approval for pharmaceutical liquid injectable products. Gland Pharma has also
Odyssey Investment Partners has completed the sale of its portfolio company One Call Care Management to funds advised by Apax Partners.
Financial terms of the transaction have not been disclosed.
Based in Jacksonville, Florida, One Call is a provider of specialised cost containment services to the workers' compensation industry.
In December 2009, Odyssey acquired One Call Medical which was merged with MSC Care Management in August 2012 to form One Call Care Management. Over the last four years, the company has grown both organically and through acquisitions.
"We set out to undertake a business transformation with One
Lynx Equity, a Canadian-based manager of private equity funds, has received USD15m in financing from Windsor Private Capital.
“This financing comes at a period of rapid growth for Lynx. It will allow us to continue with our acquisition strategy and diversify our portfolio. This has been a record year for Lynx, and we couldn’t be more pleased to have Windsor as a partner in this success,” says Lynx president Brad Nathan.
Lynx has acquired four new subsidiaries this fiscal year, with plans to close five more before the end of fiscal 2014 bringing its total portfolio to 35 companies.
INE Ventures has launched INE Ventures Fund I, which will co-invest seed capital in Israeli technology start-ups with a selection of trusted venture capital partners.
Portfolio company founders will relocate to Philadelphia and New York City to help them penetrate the US market and turn into growing multinational companies.
“The goal of INE Ventures is to take exciting but unproven Israeli technology companies and work closely with their founders to grow them into viable and scalable businesses with strong traction in the US market,” says Paul Grossinger, managing partner of INE Ventures.
Israel, termed the “Start-up Nation,” is
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
